Discounted Cash Flow Rating

Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Neutral

Analyst Rating

Sell

Simple Moving Average

Sell

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Neutral

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Vor Biopharma Inc. Common Stock (VOR)

Biological Products, (no Disgnostic Substances)

https://www.vorbio.com

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.

100 CAMBRIDGEPARK DRIVE, SUITE 101
CAMBRIDGE, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/05/2021

Market Cap

64,664,226

Shares Outstanding

67,810,000

Weighted SO

67,805,687

Total Employees

N/A

Upcoming Earnings

N/A

Beta

-0.3420

Last Div

0.0000

Range

0.7-3.14

Chg

0.0499

Avg Vol

332674

Mkt Cap

64664226

Exch

NASDAQ

Country

US

Phone

617 655 6580

DCF Diff

1.0359

DCF

-0.0640

Div Yield

0.0000

P/S

5.2891

EV Multiple

-0.1836

P/FV

0.6583

Div Yield %

0.0000

P/E

-0.5468

PEG

-0.0232

Payout

0.0000

Current Ratio

6.5398

Quick Ratio

6.5398

Cash Ratio

5.5124

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

151.8563

CCC

-151.8563

Gross Margin

0.6054

Op Margin

-10.2078

Pretax Margin

-9.6593

Net Margin

-9.6593

Eff Tax Rate

-0.0245

ROA

-0.8341

ROE

-0.8642

ROCE

-0.9766

NI/EBT

1.0000

EBT/EBIT

0.9463

EBIT/Rev

-10.2078

Debt Ratio

0.2389

D/E

0.3448

LT Debt/Cap

0.2325

Total Debt/Cap

0.2564

Int Coverage

-62.7456

CF/Debt

-3.0821

Equity Multi

1.4436

Rec Turnover

0.0000

Pay Turnover

2.4036

Inv Turnover

0.0000

FA Turnover

0.2666

Asset Turnover

0.0863

OCF/Share

-1.5262

FCF/Share

-1.5364

Cash/Share

1.2583

OCF/Sales

-8.5258

FCF/OCF

1.0067

CF Coverage

-3.0821

ST Coverage

-25.3431

CapEx Coverage

-149.1216

Div&CapEx Cov

-149.1216

P/BV

0.6583

P/B

0.6583

P/S

5.2891

P/E

-0.5468

P/FCF

-0.6162

P/OCF

-0.6195

P/CF

-0.6195

PEG

-0.0232

P/S

5.2891

EV Multiple

-0.1836

P/FV

0.6583

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation